placeholder

Stemnovate raises more than £1m to expand commercialisation of its drug discovery and diagnostic technology

06/08/2021

Stemnovate has raised more than £1million to bolster the commercialisation of its drug discovery and diagnostic technologies.

The Babraham Research Campus-based company worked with Gary Douglas Beet at Innovate UK Edge to raise the funding through the Enterprise Investment Scheme (EIS), which offers tax reliefs to investors.

Read the full article here